GNMSF:OTCMKTS
Genmab
271,82 US$
0,00%
(0,00) 1K
22-apr, 11:30:57 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGNMSF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
16,96 mlrd
Oʻrtacha hajm
23,00
Hajmi
0,00
52 haftalik eng yuqori
352,00 US$
52 haftalik eng past
188,80 US$
Beta
0,91
Muomaladagi aksiyalar
64,25 mln
Xodimlar soni
3 ming
Yangiliklar
Internetdagi manbalardan
AOL.com
·
2 daqiqa oldin
Scaramucci's 'Biggest Investing Mistake Has Always Been Selling Too Early'
TheStreet
·
22 daqiqa oldin
Nasdaq’s CEO declared the stock market is about to change forever
The Manila Times
·
25 daqiqa oldin
urban-gro, Inc. (Nasdaq: UGRO) Issues Comprehensive Business Update: Strategic Transformation from Controlled Environment Agriculture to Sports, Media, and Experiential Platform; Restored Nasdaq Listing Compliance; Cricket Strategy Aligned with LA28
GlobeNewswire
·
29 daqiqa oldin
Greenlane Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Genmab haqida
CEOJan G. J. van de Winkel
Xodimlar soni2,97 ming
Asos solingan1999
Bosh ofislar-
Sektor-
Veb-saytgenmab.com
AI kontentda xatolar boʻlishi mumkin. Batafsil